ClinicalTrials.govpublic full text
Immunogenicity, Efficacy and Safety of QazCovid-in® COVID-19 Vaccine
covid19, sars-cov infection, vaccine adverse reaction, qazcovid-in®, vaccine, iii phase, efficiency, safety, immunogenicity, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 991692
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.